News | Heart Failure | January 07, 2016

New Study Finds Genetic Basis for Heart Failure in Pregnant Women

Researchers discover protein coding mutation leads to thin heart walls, which impedes pumping of blood; could allow closer monitoring, preventative treatment

PPCM, peripartum cardiomyopathy, clinical study, titin protein, genetic mutation

January 7, 2016 — Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or shortly after giving birth share certain genetic changes.

The finding provides some explanation for this mysterious condition, and suggests that by testing relatives, other women who carry the same genes and who might face similar risks could be identified early. They could then be monitored closely and treated more swiftly if needed. In the future preventative treatment might be developed too.

Normal pregnancy is a challenge for the cardiovascular system, with up to a 25 percent increase in heart rate, and 50 percent increase in the volume of blood pumped in a minute. In some previously healthy women the heart just can’t cope. Around the time of childbirth the heart enlarges, and stops pumping properly – classic symptoms of heart failure. This can lead to death or the need for a heart transplant, and at the moment doctors don’t know who this will happen to.

Around 1 in every 1,000 women in Europe and the United States suffers from this condition, known as peripartum cardiomyopathy (PPCM). Elsewhere there are geographic hotspots, including Nigeria and Haiti, where the number can be as high as 1 in 100.

Women who suffer from pre-eclampsia, those pregnant with twins and older pregnant women are all known to be at higher risk of developing PPCM. The cause is unknown, though theories about contributing factors include an auto-immune response, undiagnosed heart damage, too much salt or too little selenium in the diet.

The teams found the 170 or so women they tested carried a higher number of genetic changes than normal. The team decoded genes that can cause rare inherited forms of cardiomyopathy, and found that women with PPCM had a very similar genetic profile to patients with dilated cardiomyopathy (DCM) – a condition that runs in families.

Cardiologist James Ware, clinical senior lecturer in genomic medicine at the Medical Research Council’s (MRC) Clinical Sciences Centre (CSC), based at Imperial College, is lead author of the paper describing the results, which he described as encouraging news: “DCM is managed as an inherited condition: First-degree relatives of affected individuals are offered genetic screening. Our results suggest that genetic diagnostics and family management may have similar value in PPCM.”

The study follows collaboration between researchers at a number of centers around the world including the Royal Brompton Hospital in London, Harvard Medical School and the Perelman School of Medicine at the University of Pennsylvania in the U.S., and is published in The New England Journal of Medicine.

The researchers found that women with PPCM and patients with DCM shared abnormalities in a gene that codes for a protein called titin. Titin is the largest protein in the human body and acts like a spring within muscle tissue, including the heart. Titin’s size is crucial to its function, and some DCM is due to mutations that disrupt titin and make the protein shorter. This leads to hearts that are ‘baggy’ and stretched with thin muscle walls, that are too weak to pump blood around the body effectively, and which can cause sudden death in the 1 in 250 people affected.

The protein’s size is altered because the patients have a mutation in the titin gene. The team found this same sort of genetic change in one in ten of the women with PPCM they studied – about the same as the proportion of patients with DCM that carry this titin-shortening variant.

“Until now, we had very little insight into the cause of peripartum cardiomyopathy,” said the study’s senior author Zoltan Arany, M.D., Ph.D., an associate professor of cardiovascular medicine in the Perelman School of Medicine at the University of Pennsylvania. “There had been theories that it was linked to a viral infection, or paternal genes attacking the mother’s circulatory system, or just the stresses of pregnancy. However, this research shows that a mutation in the TTN (titin) gene is the cause of a significant number of peripartum cardiomyopathies, even in women without a family history of the disease.”

The researchers found that in women with this genetic variant their heart was pumping less well after a year. Testing for this change may therefore prove a useful way to predict likely outcome, enabling closer surveillance of those at higher risk.

Arany added: "These findings will certainly inform future peripartum cardiomyopathy research, with possible implications on genetic testing and preventative care, though more research is unquestionably needed. We’re continuing to follow these women and we’re gathering data for hundreds of others around the world, with the goal of identifying the cause of peripartum cardiomyopathy in the remaining 85 percent of women with this condition, and ultimately using what we learn to improve the care of these women and their newborns.”

This latest study was led by Zoltan Arany in the Perelman School of Medicine at the University of Pennsylvania together with professors Christine and Jon and Seidman and Dennis McNamara at the University of Pittsburgh Medical Center. Co-authors include Stuart Cook, M.D., who leads the Cardiovascular Magnetic Resonance Imaging and Genetics group at the CSC; Sanjay Prasad, M.D., a consultant cardiologist and honorary senior lecturer at Imperial College; and Francesco Mazzarotto, a Ph.D. student working with Cook and Ware at the National Heart and Lung Institute.

The study builds on a substantial program of research around the role of titin in the heart by the teams from the CSC, Imperial College and Harvard.

The patients with dilated cardiomyopathy were recruited by the NIHR Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London.

For more information: www.csc.mrc.ac.uk

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics| January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics| December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics| December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics| December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics| December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics| December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics| November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics| November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics| October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
The Role of Telomere Length in Cardiovascular Risk Assessment
Feature | Cardiac Diagnostics| October 19, 2017 | Nanette H. Bishopric, M.D., FACC, FAHA
A new area of DNA testing involving telomere length may enhance a patient’s cardiovascular disease risk stratificatio
Overlay Init